Lymph Node Hepatocyte Transplantation for Liver Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for ectopic liver transplantation, such as placing hepatocytes at sites like the peritoneum or lung parenchyma, have failed to sufficiently restore liver function due to inadequate engraftment and expansion of transplanted cells, leading to a need for a more effective method to promote engraftment and expansion of liver cells.
Innovation Solution
Transplanting hepatocytes, islet cells, and thymocytes into lymph nodes, using immunosuppressants like FK506 to overcome allogeneic graft responses, and employing stem cells or reprogrammed cells to expand hepatocytes within lymph nodes, which can later be harvested for implantation, thereby enhancing liver function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If hepatocytes are transplanted at ectopic sites such as peritoneum or lung parenchyma, then the transplantation procedure can be performed, but the transplanted cells cannot engraft and expand sufficiently to restore liver function
Solution Approach 1:
The patent applies local quality by selecting lymph nodes as a specific ectopic site with unique properties that promote hepatocyte engraftment and expansion. The lymph node microenvironment provides specific structural and cellular characteristics that differ from other ectopic sites, creating a favorable local condition for cell survival and proliferation.
Solution Approach 2:
The patent uses lymph nodes as an intermediary structure that facilitates hepatocyte engraftment. The lymph node acts as a mediator between the transplanted hepatocytes and the host tissue, providing a supportive microenvironment that enables cell integration and functional recovery.
2Reliability
If allogeneic hepatocytes are transplanted to restore liver function, then therapeutic effect can be achieved, but allogeneic graft responses must be overcome requiring immunosuppressants
Solution Approach 1:
The patent employs lymph nodes as an intermediary site that may modulate immune responses. The lymph node microenvironment could potentially reduce allogeneic rejection by providing a protected niche for hepatocyte engraftment, thereby reducing the complexity of managing graft responses.
Solution Approach 2:
The patent changes the parameter of transplantation site from conventional ectopic sites to lymph nodes, which may alter the immunological parameters of the graft environment. This parameter change could influence immune recognition and rejection mechanisms.
Data Source
AI summary
Methods of transplanting cells, such as hepatocytes, are presented herein. Such methods are useful for treating liver disease as well as other disorders.